Suter, Thomas M <br/><br/>
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Sep 2007 
 - 3859-65 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2006.09.1611  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Cardiovascular Diseases--chemically induced<br/>Disease-Free Survival<br/>Female<br/>Heart Failure--chemically induced<br/>Humans<br/>Middle Aged<br/>Receptor, ErbB-2--metabolism<br/>Trastuzumab